Epilepsy Clinical Trials in Los Angeles

Showing 61-80 of 102 trials

Study in Pediatric Subjects With Epilepsy

NCT01494584

This is an open-label study to evaluate the pharmacokinetics, safety and tolerability of ezogabine/retigabine in subjects aged 12 years to less than 18 years with uncontrolled partial onset seizures or Lennos-Gastaut syndrome.

Epilepsy

GlaxoSmithKline5 participantsStarted Jul 2012

Los Angeles, California, United States • Wellington, Florida, United States • Memphis, Tennessee, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452

The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.

Childhood Absence EpilepsyPetit Mal EpilepsyEpilepsy+1 more

Children's Hospital Medical Center, Cincinnati453 participantsStarted Jul 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +28 more locations

Study in Pediatric Subjects With Epilepsy

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Epilepsy Trials in Other Cities

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Does Use of Rapid Response EEG Impact Clinical Decision Making

RNS® System LTT Study

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Radiosurgery or Open Surgery for Epilepsy Trial

Eslicarbazepine Acetate Monotherapy Long Term Study

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Neocortical Epilepsies - Do They Progress?

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

Other Conditions in Los Angeles